{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:12:27Z","timestamp":1788441147124,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FISR2020IP - 04530"],"award-info":[{"award-number":["FISR2020IP - 04530"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009873","name":"Regione Autonoma della Sardegna","doi-asserted-by":"publisher","award":["CRP 59740"],"award-info":[{"award-number":["CRP 59740"]}],"id":[{"id":"10.13039\/501100009873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009873","name":"Regione Autonoma della Sardegna","doi-asserted-by":"publisher","award":["RASSR 81788"],"award-info":[{"award-number":["RASSR 81788"]}],"id":[{"id":"10.13039\/501100009873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejmech.2021.114002","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T21:21:12Z","timestamp":1637184072000},"page":"114002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Design, synthesis and biological evaluation of 1,5-disubstituted \u03b1-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders"],"prefix":"10.1016","volume":"229","author":[{"given":"Fausta","family":"Ulgheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Spanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Deligia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Loriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Fuggetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Chandgudge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9859-5177","authenticated-orcid":false,"given":"Matthew","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9923-8873","authenticated-orcid":false,"given":"Alexander","family":"Domling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejmech.2021.114002_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.114002_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.12296","article-title":"Regulation of inflammasome activation","volume":"265","author":"Man","year":"2015","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.ejmech.2021.114002_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ejmech.2021.114002_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.ejmech.2021.114002_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124223","article-title":"Focus on the role of NLRP3 inflammasome in diseases","volume":"21","author":"Fusco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2021.114002_bib6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.molmed.2020.07.010","article-title":"Advances in inflammasome research: recent breakthroughs and future hurdles","volume":"26","author":"Tweedell","year":"2020","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.ejmech.2021.114002_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00281-015-0485-5","article-title":"Protective and detrimental roles of inflammasomes in disease","volume":"37","author":"Saavedra","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ejmech.2021.114002_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jnc.13217","article-title":"The pathogenic role of the inflammasome in neurodegenerative diseases","volume":"136","author":"Freeman","year":"2015","journal-title":"J.\u00a0Neurochem."},{"issue":"2","key":"10.1016\/j.ejmech.2021.114002_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molcel.2014.03.029","article-title":"Inflammasomes and metabolic disorders: old genes in modern diseases","volume":"54","author":"Robbins","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2021.114002_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-012414-040431","article-title":"The inflammasomes and autoinflammatory syndromes","volume":"10","author":"Broderick","year":"2015","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejmech.2021.114002_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.570711","article-title":"The role of microglia and the Nlrp3 inflammasome in alzheimer's disease","volume":"11","author":"Hanslik","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejmech.2021.114002_bib12","first-page":"15","article-title":"Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives","volume":"8","author":"Ozaki","year":"2015","journal-title":"J.\u00a0Inflamm. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2021.114002_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10787-017-0401-9","article-title":"Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain","volume":"26","author":"Khan","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.ejmech.2021.114002_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.trsl.2015.05.003","article-title":"Therapeutics targeting the inflammasome after central nervous system injury","volume":"167","author":"De Rivero Vaccari","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejmech.2021.114002_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2017.00063","article-title":"NLRP3 inflammasome in neurological diseases, from functions to therapies","volume":"11","author":"Song","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2021.114002_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lfs.2015.05.011","article-title":"NALP3 inflammasome activation in protein misfolding diseases","volume":"135","author":"Shi","year":"2015","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2021.114002_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.117","article-title":"Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies","volume":"47","author":"Ciechanover","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2021.114002_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2021.114002_bib19","first-page":"9169","article-title":"SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications?","volume":"24","author":"Quagliariello","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2021.114002_bib20","doi-asserted-by":"crossref","first-page":"756","DOI":"10.14336\/AD.2020.0601","article-title":"Age-induced NLRP3 inflammasome over-activation increases lethality of SARS-CoV-2 pneumonia in elderly patients","volume":"11","author":"Lara","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.ejmech.2021.114002_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01021","article-title":"Novel coronavirus-induced NLRP3 inflammasome activation: a potential drug target in the treatment of COVID-19","volume":"11","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2021.114002_bib22","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41375-020-0887-9","article-title":"SARS-CoV-2 infection and overactivation of NLRP3 inflammasome as a trigger of cytokine \u201cstorm\u201d and risk factor for damage of hematopoietic stem cells","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2021.114002_bib23","first-page":"1","article-title":"Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats","author":"Nagaraja","year":"2021","journal-title":"J.\u00a0Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2021.114002_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2021.114002_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.20172222","article-title":"Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity","volume":"215","author":"Boucher","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"issue":"5a","key":"10.1016\/j.ejmech.2021.114002_bib26","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/j.1582-4934.2008.00292.x","article-title":"Caspases as therapeutic targets","volume":"12","author":"Howley","year":"2008","journal-title":"J.\u00a0Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.ejmech.2021.114002_bib27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/cns.13384","article-title":"Caspase-1 inhibition prevents neuronal death by targeting the canonical inflammasome pathway of pyroptosis in a murine model of cerebral ischemia","volume":"26","author":"Li","year":"2020","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2021.114002_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01927-w","article-title":"Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair","volume":"17","author":"Israelov","year":"2020","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ejmech.2021.114002_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18405-9","article-title":"Pre-symptomatic caspase-1 inhibitor delays cognitive decline in a mouse model of alzheimer disease and aging","volume":"11","author":"Flores","year":"2020","journal-title":"Nat. Commun."},{"issue":"34","key":"10.1016\/j.ejmech.2021.114002_bib30","doi-asserted-by":"crossref","first-page":"9593","DOI":"10.1073\/pnas.1609291113","article-title":"Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system Atrophy","volume":"113","author":"Bassil","year":"2016","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2021.114002_bib31","series-title":"ICE Cleaved Alpha-Synuclein as a Biomarker, WO 2012\/061786 A1","author":"Ringe","year":"2012"},{"issue":"4","key":"10.1016\/j.ejmech.2021.114002_bib32","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.4049\/jimmunol.175.4.2630","article-title":"IL-converting enzyme\/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients","volume":"175","author":"Stack","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.114002_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2017.05.040","article-title":"Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6-dependent inhibiton of STAT3","volume":"656","author":"Wanga","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2021.114002_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/138161207780163006","article-title":"Inflammatory caspases: targets for novel therapies","volume":"13","author":"Cornelis","year":"2007","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2021.114002_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06449-x","article-title":"Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an alzheimer's disease mouse model","volume":"9","author":"Flores","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2021.114002_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13543776.2017.1378426","article-title":"Caspase inhibitors: a review of recently patented compounds (2013-2015)","volume":"28","author":"Lee","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.ejmech.2021.114002_bib37","first-page":"473","article-title":"Pharmacological caspase inhibitors: research towards therapeutic perspectives","volume":"66","author":"Kudelova","year":"2015","journal-title":"J.\u00a0Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.114002_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acs.jmedchem.0c01307","article-title":"Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space","volume":"64","author":"Schwaid","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2021.114002_bib39","doi-asserted-by":"crossref","first-page":"12546","DOI":"10.1021\/acs.chemrev.5b00434","article-title":"Small molecule active site directed tools for studying human caspases","volume":"115","author":"Poreba","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.114002_bib40","series-title":"Design Of Caspase Inhibitors as Potential Clinical Agents; CRC Enzyme Inhibitors Series","first-page":"75","article-title":"Kinetics and catalytic activity of caspases","author":"Nalley","year":"2009"},{"issue":"6","key":"10.1016\/j.ejmech.2021.114002_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd9307","article-title":"Multicomponent reaction-derived covalent inhibitor space","volume":"7","author":"Sutanto","year":"2021","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.ejmech.2021.114002_bib42","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/cr100233r","article-title":"Chemistry and biology of multicomponent reactions","volume":"112","author":"D\u00f6mling","year":"2012","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.ejmech.2021.114002_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13543776.2021.1858797","article-title":"Multicomponent reactions (MCR) in medicinal chemistry: a patent review (2010-2020)","volume":"31","author":"Younus","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.114002_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1021\/acsmedchemlett.8b00579","article-title":"Atorvastatin (lipitor) by MCR","volume":"10","author":"Zarganes-Tzitzikas","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"41","key":"10.1016\/j.ejmech.2021.114002_bib45","doi-asserted-by":"crossref","first-page":"12296","DOI":"10.1002\/chem.201002046","article-title":"Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel","volume":"16","author":"Cao","year":"2010","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2021.114002_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111826","article-title":"Applications of fluorine-containing amino acids for drug design","volume":"186","author":"Mei","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114002_bib47","article-title":"Editorial: isocyanide-based multicomponent reactions","volume":"7","author":"Rudick","year":"2019","journal-title":"Front. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2021.114002_bib48","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1021\/acs.chemrev.8b00564","article-title":"Tetrazoles via multicomponent reactions","volume":"119","author":"Neochoritis","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.114002_bib49","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1039\/C7CC03370B","article-title":"With unprotected amino acids to tetrazolo peptidomimetics","volume":"53","author":"Madhavachary","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.114002_bib50","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/chem.201504520","article-title":"\u03b1-Amino acid-isosteric \u03b1-amino tetrazoles","volume":"22","author":"Zhao","year":"2016","journal-title":"Chem. Eur J."},{"issue":"1","key":"10.1016\/j.ejmech.2021.114002_bib51","article-title":"Reactor was used for enumeration and reaction modeling","volume":"6","year":"2014","journal-title":"J.\u00a0Chem."},{"key":"10.1016\/j.ejmech.2021.114002_bib53","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1073\/pnas.0602571103","article-title":"A\u00a0common allosteric site and mechanism in caspases","volume":"103","author":"Scheer","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"6","key":"10.1016\/j.ejmech.2021.114002_bib54","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2131\/jts.42.763","article-title":"Macrophage differentiation induced by PMA is mediated by activation of RhoA\/ROCK signaling","volume":"42","author":"Yang","year":"2017","journal-title":"J.\u00a0Toxicol. Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2021.114002_bib55","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1002\/jcb.25983","article-title":"Ameloblastin upregulates inflammatory response through induction of IL-1\u03b2 in human macrophages","volume":"118","author":"Otsuka","year":"2017","journal-title":"J.\u00a0Cell. Biochem."},{"issue":"12","key":"10.1016\/j.ejmech.2021.114002_bib56","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:02:35Z","timestamp":1777528955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":55,"alternative-id":["S0223523421008515"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114002","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of 1,5-disubstituted \u03b1-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114002"}}